Notice of Correction to Application Instructions for RFA-DK-17-025 "Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional)"

Notice Number: NOT-DK-18-015

Key Dates
Release Date: April 20, 2018

Related Announcements
RFA-DK-17-025

Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to correct language in Section IV.2 Application and Submission Information, Content and Form of Application Submission, SF424(R&R) Cover to remove the additional instructions related to Estimated Project Funding. The appropriate Modular or R&R Budget form must be uploaded.
 
Current Language:

SF424(R&R) Cover 
All instructions in the SF424 (R&R) Application Guide must be followed.

Estimated Project Funding: Enter the budget request on the face page only. This number should include total costs (direct and indirect) for the entire project period. Note that a detailed budget cannot be accepted in the application; it will be requested as part of the Just-in-Time information. 

Revised Language:
SF424(R&R) Cover
All instructions in the SF424 (R&R) Application Guide must be followed.
Estimated Project Funding:? All instructions in the SF424 (R&R) Application Guide must be followed. There are no additional instructions for Estimated Project Funding specific to this FOA.
 
All other aspects of this Funding Opportunity Announcement remain the same.

Inquiries

Please direct all inquiries to:

Guillermo Arreaza-Rubin, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-4724
Email: arreazag@mail.nih.gov